Subtherapeutic posaconazole exposure during delayed-release tablet prophylaxis in high-risk patients with haematological malignancies: rationale for routine therapeutic drug monitoring. (academic.oup.com)

Authors: Urbancic KF … Slavin MA Journal: Journal of Antimicrobial Chemotherapy Published: 2026-07-02 DOI: https://doi.org/10.1093/jac/dkag233